CA2153677C - Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials - Google Patents
Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials Download PDFInfo
- Publication number
- CA2153677C CA2153677C CA002153677A CA2153677A CA2153677C CA 2153677 C CA2153677 C CA 2153677C CA 002153677 A CA002153677 A CA 002153677A CA 2153677 A CA2153677 A CA 2153677A CA 2153677 C CA2153677 C CA 2153677C
- Authority
- CA
- Canada
- Prior art keywords
- cell
- chamber
- ligand
- substrate
- cell portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012620 biological material Substances 0.000 title claims abstract description 24
- 238000012545 processing Methods 0.000 title claims description 16
- 238000005538 encapsulation Methods 0.000 title description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 55
- 239000000758 substrate Substances 0.000 claims abstract description 49
- 239000003446 ligand Substances 0.000 claims abstract description 46
- 239000012530 fluid Substances 0.000 claims abstract description 32
- 238000004891 communication Methods 0.000 claims abstract description 16
- 238000010438 heat treatment Methods 0.000 claims description 23
- 230000002093 peripheral effect Effects 0.000 claims description 19
- 239000007788 liquid Substances 0.000 claims description 10
- 238000001816 cooling Methods 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000012212 insulator Substances 0.000 claims description 6
- 238000007789 sealing Methods 0.000 claims description 6
- 239000011810 insulating material Substances 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 abstract description 62
- 239000011159 matrix material Substances 0.000 abstract description 35
- 210000005056 cell body Anatomy 0.000 abstract description 29
- 239000000523 sample Substances 0.000 abstract description 19
- 108010010803 Gelatin Proteins 0.000 abstract description 16
- 239000008273 gelatin Substances 0.000 abstract description 16
- 229920000159 gelatin Polymers 0.000 abstract description 16
- 235000019322 gelatine Nutrition 0.000 abstract description 16
- 235000011852 gelatine desserts Nutrition 0.000 abstract description 16
- 239000012472 biological sample Substances 0.000 abstract description 15
- 238000000034 method Methods 0.000 abstract description 15
- 239000007787 solid Substances 0.000 abstract description 8
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 2
- 230000000694 effects Effects 0.000 abstract description 2
- 238000012760 immunocytochemical staining Methods 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 21
- 239000002775 capsule Substances 0.000 description 9
- 239000001993 wax Substances 0.000 description 9
- 239000000427 antigen Substances 0.000 description 7
- 102000036639 antigens Human genes 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 239000000872 buffer Substances 0.000 description 5
- 230000000087 stabilizing effect Effects 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036571 hydration Effects 0.000 description 3
- 238000006703 hydration reaction Methods 0.000 description 3
- 238000003365 immunocytochemistry Methods 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000003298 DNA probe Substances 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000004809 Teflon Substances 0.000 description 2
- 229920006362 Teflon® Polymers 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 210000003850 cellular structure Anatomy 0.000 description 2
- 238000001311 chemical methods and process Methods 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical compound FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 description 2
- 239000000263 2,3-dihydroxypropyl (Z)-octadec-9-enoate Substances 0.000 description 1
- HAEVLZUBSLBWIX-UHFFFAOYSA-N 2-octylphenol;oxirane Chemical compound C1CO1.CCCCCCCCC1=CC=CC=C1O HAEVLZUBSLBWIX-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-GDCKJWNLSA-N 3-oleoyl-sn-glycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@H](O)CO RZRNAYUHWVFMIP-GDCKJWNLSA-N 0.000 description 1
- 229920000945 Amylopectin Polymers 0.000 description 1
- 229920000856 Amylose Polymers 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 108010001336 Horseradish Peroxidase Proteins 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 101710163270 Nuclease Proteins 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 238000001493 electron microscopy Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- 230000001744 histochemical effect Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000012744 immunostaining Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000002923 metal particle Substances 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- UYDLBVPAAFVANX-UHFFFAOYSA-N octylphenoxy polyethoxyethanol Chemical compound CC(C)(C)CC(C)(C)C1=CC=C(OCCOCCOCCOCCO)C=C1 UYDLBVPAAFVANX-UHFFFAOYSA-N 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 239000004296 sodium metabisulphite Substances 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/5436—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand physically entrapped within the solid phase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
- G01N1/31—Apparatus therefor
- G01N1/312—Apparatus therefor for samples mounted on planar substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/36—Embedding or analogous mounting of samples
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N35/00—Automatic analysis not limited to methods or materials provided for in any single one of groups G01N1/00 - G01N33/00; Handling materials therefor
- G01N2035/00178—Special arrangements of analysers
- G01N2035/00237—Handling microquantities of analyte, e.g. microvalves, capillary networks
- G01N2035/00247—Microvalves
- G01N2035/00267—Meltable plugs
Abstract
There is disclosed an automated apparatus and process for immunocytochemical staining of biological materials using ligand pairing.
The apparatus includes an array of sample cells interconnected with reagent supply and drainage lines. Each cell encloses a fluid chamber into which a sample substrate is inserted. The face of the substrate onto which a biological sample is mounted faces into a fluid well. The cell includes a cell head having a chamber to receive therein a solid support matrix releasably containing a ligand to be contacted with the sample. The chamber in the cell head is in flow communication with the fluid well so that when the ligand is released from the matrix it flows into the fluid well thereby contacting the mounted biological sample.
The ligand support matrix may be gelatin or wax. The cell body and cell head are differentially heated or cooled so that the mounted sample may be held at the preferred temperature for the reaction of interest and the cell head may be heated to a temperature sufficient to cause thermal degradation of the matrix to effect release of the ligand. Control electronics is provided for sensing and controlling the temperature of the various cell parts and for progammable control of reagent supply to the cells.
The apparatus includes an array of sample cells interconnected with reagent supply and drainage lines. Each cell encloses a fluid chamber into which a sample substrate is inserted. The face of the substrate onto which a biological sample is mounted faces into a fluid well. The cell includes a cell head having a chamber to receive therein a solid support matrix releasably containing a ligand to be contacted with the sample. The chamber in the cell head is in flow communication with the fluid well so that when the ligand is released from the matrix it flows into the fluid well thereby contacting the mounted biological sample.
The ligand support matrix may be gelatin or wax. The cell body and cell head are differentially heated or cooled so that the mounted sample may be held at the preferred temperature for the reaction of interest and the cell head may be heated to a temperature sufficient to cause thermal degradation of the matrix to effect release of the ligand. Control electronics is provided for sensing and controlling the temperature of the various cell parts and for progammable control of reagent supply to the cells.
Description
WO 94/18539 ~ ~ PCTICA94100061 AUTOMATED HISTO-CYTOCHEMISTRY APPARATUS AND
ENCAPSULATION SYSTEM FOR PROCESSING BIOLOGICAL
MATERIALS
FIELD OF THE INVENTION
The present invention relates to a method and apparatus for processing biological materials utilizing ligand pairing and relates more particularly to the field of microscopical analysis where one member of a ligand pair is to be detected in a biological sample mounted on a support substrate.
BACKGROUND OF THE INVENTION
To examine the structure of biological samples such as tissues (histology) or cells (cytology), microscopical preparations are made by mounting the sample on a substrate such as a microscope slide. These preparations are routinely stained with dyes to facilitate microscopical examination. To further aid in the identification of the samples, specialized procedures under the general headings of histochemistry (tissue slices) and cytochemistry (biological cell smears) are applied to these preparations. One class of procedures for processing biological materials involves ligand-pair formation wherein a first member of the ligand pair may be present in the biological sample and the other member of the pair binds to the first member when contacted with the sample. Examples of such biologically based ligand-pairs include antibody/antigen couples. lectins/sugars, hormone/receptor systems, enzymelsubstrates. DNA/DNA and DNA/RNA couples.
Processing of biological materials involving the antibodylantigen couple forms the basis of immunohisto- and immunocytochemistry. Until recently the staining of mounted samples using these reactions has been performed manually. Present machines currently known for immuno-staining of samples dispense the antibody containing solutions in liquid form into the fluid well containing the supported sample. These machines require considerable operator attention which entails high labour costs and are prone to suffer from operator error at the stages of dilution, pipetting and loading of reagents. Furthermore, in many circumstances it may be desirable to detect different antigens on an ad hoc basis but the primary antibodies are expensive and prone to deterioration. In addition, the difficulties of working with a large number of small volumes used for a multitude of different tests has acted as a bar to the development of an optimally automated immunocytochemistry staining system.
Accordingly, it is desirable to provide a process and apparatus for automated processing of biological materials involving ligand pair formation which avoids the need to prepare antisera immediately prior to use and which does not require accurate positioning and alignment of the sample substrates.
SUMMARY OF THE INVENTION
The present invention provides an apparatus for processing biological materials using ligand pairing, the biological material being mounted on a surface of a substrate. The apparatus comprises a housing provided with at least one cell, said at least one cell comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening; means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
In another aspect of the invention there is provided an apparatus for processing biological materials using ligand pairing, the biological material being mounted on a surface of a substrate, the apparatus comprising a housing provided with an array of cells, each cell of said array comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a iigand, the second chamber being in fluid flow communication with said first chamber through said first opening, the first and second cell portions being separated by a thermal insulator; means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
In another aspect of the invention there is provided an apparatus for processing biological materials using ligand pairing, the biological material being mounted on a surface of a substrate, comprising a housing provided with at least one cell fabricated of a thermally insulating material, said at least one cell comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening; means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
ENCAPSULATION SYSTEM FOR PROCESSING BIOLOGICAL
MATERIALS
FIELD OF THE INVENTION
The present invention relates to a method and apparatus for processing biological materials utilizing ligand pairing and relates more particularly to the field of microscopical analysis where one member of a ligand pair is to be detected in a biological sample mounted on a support substrate.
BACKGROUND OF THE INVENTION
To examine the structure of biological samples such as tissues (histology) or cells (cytology), microscopical preparations are made by mounting the sample on a substrate such as a microscope slide. These preparations are routinely stained with dyes to facilitate microscopical examination. To further aid in the identification of the samples, specialized procedures under the general headings of histochemistry (tissue slices) and cytochemistry (biological cell smears) are applied to these preparations. One class of procedures for processing biological materials involves ligand-pair formation wherein a first member of the ligand pair may be present in the biological sample and the other member of the pair binds to the first member when contacted with the sample. Examples of such biologically based ligand-pairs include antibody/antigen couples. lectins/sugars, hormone/receptor systems, enzymelsubstrates. DNA/DNA and DNA/RNA couples.
Processing of biological materials involving the antibodylantigen couple forms the basis of immunohisto- and immunocytochemistry. Until recently the staining of mounted samples using these reactions has been performed manually. Present machines currently known for immuno-staining of samples dispense the antibody containing solutions in liquid form into the fluid well containing the supported sample. These machines require considerable operator attention which entails high labour costs and are prone to suffer from operator error at the stages of dilution, pipetting and loading of reagents. Furthermore, in many circumstances it may be desirable to detect different antigens on an ad hoc basis but the primary antibodies are expensive and prone to deterioration. In addition, the difficulties of working with a large number of small volumes used for a multitude of different tests has acted as a bar to the development of an optimally automated immunocytochemistry staining system.
Accordingly, it is desirable to provide a process and apparatus for automated processing of biological materials involving ligand pair formation which avoids the need to prepare antisera immediately prior to use and which does not require accurate positioning and alignment of the sample substrates.
SUMMARY OF THE INVENTION
The present invention provides an apparatus for processing biological materials using ligand pairing, the biological material being mounted on a surface of a substrate. The apparatus comprises a housing provided with at least one cell, said at least one cell comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening; means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
In another aspect of the invention there is provided an apparatus for processing biological materials using ligand pairing, the biological material being mounted on a surface of a substrate, the apparatus comprising a housing provided with an array of cells, each cell of said array comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a iigand, the second chamber being in fluid flow communication with said first chamber through said first opening, the first and second cell portions being separated by a thermal insulator; means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
In another aspect of the invention there is provided an apparatus for processing biological materials using ligand pairing, the biological material being mounted on a surface of a substrate, comprising a housing provided with at least one cell fabricated of a thermally insulating material, said at least one cell comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening; means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
In another aspect of the invention there is provided a process for releasing a ligand onto a biological sample mounted on a substrate. The process comprises the steps of containing the ligand in a releasable containment means. The releasable containment means is held in a chamber in flow communication with the biological sample. The releasable containment means is disintegratable if heated to within a predetermined temperature range thereby to release the ligand The process includes heating the releasable containment means to within the predetermined temperature range and flowing the ligand onto the biological sample.
In another aspect of the invention there is provided a method of storing a ligand in a releasable containment means comprising mixing a predetermined amount of the ligand with a material which can be formed into a support matrix to encapsulate said ligand, said support matrix being responsive to release means to release the ligand therefrom. In this aspect of the invention the material from which the releasable containment means is made may be wax or gelatin and the ligand released therefrom using heat.
Alternatively, the material could be starch or sugars and the ligands released by exposing the support matrix to an aqueous solution.
BRIEF DESCRIPTION OF THE DRAWINGS
The process and apparatus for processing biological materials forming the present invention will now be described, by way of example only, reference being had to the drawings, in which:
Figure 1 is a perspective view of an embodiment of an apparatus for processing biological materials forming part of the subject invention;
Figure 2 is a view along the line 2-2 of Figure 1;
Figure 3 is a clamshell exploded perspective view of the two cells shown in section in Figure 2;
Figure 4 is a schematic representation of an embodiment of a reagent flow system forming part of the apparatus;
Figure 5 is a front view of an embodiment of a containing means which may be used with the apparatus forming the subject invention;
In another aspect of the invention there is provided a method of storing a ligand in a releasable containment means comprising mixing a predetermined amount of the ligand with a material which can be formed into a support matrix to encapsulate said ligand, said support matrix being responsive to release means to release the ligand therefrom. In this aspect of the invention the material from which the releasable containment means is made may be wax or gelatin and the ligand released therefrom using heat.
Alternatively, the material could be starch or sugars and the ligands released by exposing the support matrix to an aqueous solution.
BRIEF DESCRIPTION OF THE DRAWINGS
The process and apparatus for processing biological materials forming the present invention will now be described, by way of example only, reference being had to the drawings, in which:
Figure 1 is a perspective view of an embodiment of an apparatus for processing biological materials forming part of the subject invention;
Figure 2 is a view along the line 2-2 of Figure 1;
Figure 3 is a clamshell exploded perspective view of the two cells shown in section in Figure 2;
Figure 4 is a schematic representation of an embodiment of a reagent flow system forming part of the apparatus;
Figure 5 is a front view of an embodiment of a containing means which may be used with the apparatus forming the subject invention;
Figure 6 is a perspective view of part of an alternative embodiment of a cell constructed in accordance with the present invention; and Figure 7 is a cross-sectional side view of the partial cell in Figure 6.
DETAILED DESCRIPTION OF THE INVENTION
Referring first to Figure 1, an automated apparatus 10 for performing the task of processing of biological materials includes a housing or sample compartment 12 comprising a plurality of sample cells 14 arranged in a rectangular array. A storage compartment 16 is located on one side of compartment 12 for housing fluid pumps, valves and reagents and a compartment 18 is located on the other side of compartment 12 for housing electronic control circuitry. An instrument panel comprising a microcomputer keypad 22 and a power switch 24 are shown as part of the control circuitry.
Details of sample cells 14 shown in Figure 1 are more clearly illustrated in Figures 2 and 3. Referring specifically to Figure 2, cells 14 are arranged in rows 30 with each row comprising a plurality of cell blocks 32 attached together. Cell block 32 includes a cell body 34 having on one side thereof a face 36 into which a rectangular shaped recess or well 38 is formed defined by wall 33. With reference to Figure 3, holes 37 and 39 are located along the bottom edge of well 38 and are in flow communication with tubes 41 and 43 respectively which are attached to the bottom of cell body 34 for supplying and draining reagents such as wash buffers to and from the cell.
In another embodiment of the cell, only one hole may be provided (not shown) for both supplying and draining reagents from the chamber. In this arrangement the hole is connected to a tube having a T junction and valve for providing a reagent inlet and outlet.
The other side of cell body 34 includes a wall 40 having a flange 42 projecting outwardly along three edges thereof. Flange 42 and cell body 34 are dimensioned so that the outer edge 44 of the flange abuts the edges of face 36 of the adjacent cell body 34 when assembled. Cell body 34 includes a liquid overflow comprising a channel 46 extending through the horizontal section of flange 42 and a tube 48 attached to the bottom edge of the flange to drain away liquid.
Referring to Figure 3, cell block 32 is provided with a head portion 50 shown attached to cell body 34 by screws 52. Alternative fastening means such as glues or epoxy may also be used. Cell body 34 and cell head 50 may be fabricated of a metal such as coated aluminum or stainless steel.
Interposed between cell body 34 and head portion 50 is a thermal insulator 54 for thermally insulating the head from the cell body. Insulator may be fabricated of a plastic such as nylon or TEFLON~. Channels 60 extend through cell body 34 and a channel 62 extends through cell head 50. Channels 60 and 62 are provided for passing fluid through the cell components for heating or cooling. Tubes 68 and 70 are secured to body 34 and head 50 respectively to provide fluid inlets and outlets. Cell body 34 and head 50 may be heated or cooled to the same temperature using a common source of heating fluid or alternatively they may be selectively heated or cooled using separate sources of fluid because of insulator 54 disposed therebetween.
In this embodiment, the apparatus 10 may include means for sensing the temperature of the cell portions.
One side of cell head 50 is provided with a surface 80 inclined at about 45 degrees to the horizontal when the cell is assembled. A leaf spring is secured to the other side of cell head 50 coplanar with wall 40 of cell body 34. Spring 82 is bowed outwardly from, and extends downwardly adjacent to, side 40 of cell body 34. The side of head 50 to which spring 82 is attached is provided with flanges 84 projecting outwardly from the side edges, flanges 84 being collinear with the vertical portions of flanges 42 on cell body 34 when the cell head is attached to the body to also sealingly engage face 36. Referring specifically to Figure 2, spring 82 acts to bias substrate 116 against face 36 but other alternative biasing means may be used including a piston arranged to bear against the back surface of the substrate slide.
Referring specifically to Figure 3, a front plate 86 is bolted to the adjacent cell block 32 at the front of each row 30. Plate 86 is provided with a planar front face 90 and back face 92 to which spring 82 is attached. The back face 92 includes a flange 42' projecting outwardly along three edges thereof and having an outer edge 44'.
A row of cells is assembled by aligning front plate 86 and a plurality of cell blocks 32 in a row and bolting them together with elongate bolts 110 extending through holes 112 in the plate and similar holes in the cell bodies 34. Alternative means of attaching the cell blocks together may be employed in addition to bolts.
Referring specifically to Figure 2, each cell 14 is formed when adjacent cell bodies 34 are attached together thereby defining a fluid chamber 114 formed between adjacent cell blocks 32. Chamber 114, which includes well 38, is defined by opposed walls 33 and 40 and is dimensioned to receive substrate 116 with the surface to which the biological material is mounted facing into well 38. Spring 82 acts to bias substrate 116 against cell body 34 with the edges of the substrate overlapping the sides and bottom edge of face 36 on either side of well 38 by about 2 mm to form a seal between the peripheral edge of substrate 116 and face 36.
The internal dimensions of fluid chamber 114 are chosen to ensure that a large enough gap exists between the opposed faces of substrate 116 and the adjacent chamber walls to prevent capillary action. For example, well 38 is of sufficient depth to prevent capillary action from retaining the fluids therein. The minimum allowable dimensions will depend on the material of construction of cell body 34 and on the material wetting properties. In one embodiment of the invention, each cell comprises fluid level sensor means (not shown) for detecting the level of a fluid in chamber 114.
A chamber or receptacle 160 is formed when cell 14 is assembled. Chamber 160 is in flow communication with well 38 when the substrate 116 is in chamber 114. Chamber 160 is dimensioned to receive a support matrix 162 containing a ligand, to be more fully discussed below. Cell head 50 may be constructed with chamber 160 having numerous shapes to act as a receptacle for support matrix 162 as long as there is an unobstructed flow path connecting chamber 160 with well 38.
Referring to Figure 4, a schematic drawing showing one _$.
embodiment of a reagent circulation system is shown generally at 130 and comprises a plurality of reagent storage containers 132 stored in reagent storage compartment 16 (Figure 1 ). Tubes 134 convey the reagents to the input of a reagent selection valve 136 located within the staining module 12, the output of which is fed to a reagent distribution value 138. Connectors 135 may be standard snap-fit connectors for conveniently connecting and disconnecting reagent containers 132. A plurality of tubes 140 connect valve 138 with chamber inlet control valves 142, one connected to each tube 41 for supplying reagents to each well 38, seen in Figure 3. Drain tubes 43 are connected to lines 150 which feeds into an outlet valve 152, the output of which is fed to a reagent waste container 154. Other fluid delivery systems will be readily apparent to those skilled in the art. For example, reagent selection valve 136 and reagent distribution valve 138 may be combined into one valve.
Alternatively, the function of reagent distribution valve 138 and chamber control valve 142 may be combined into one valve associated with each chamber.
Referring to Figure 2, cell body 34 and head portion 50 may be differentially heated or cooled by water circulated through the body and head by separate pumps and heaters. The pumps and heaters are controlled using standard controllers under microprocessor control. The controllers, pumps and microprocessor may be located in compartments 16 or 18 (Figure 1 ) or alternatively may be located external to apparatus 10.
Those skilled in the art will appreciate that numerous other embodiments of apparatus 10 may be made. For example, instead of differentially heating with water, small resistance electrical heaters may be embedded into cell body 34 and cell head 50, the heaters being connected to a dual channel electrical power supply. Standard thermocouples may be attached to the two cell components forming part of the control system.
Substrate 116 may be a standard microscope slide. However, other substrates may be used as well. For example, chamber 114 may be designed to receive substrates comprising an electron microscope grid on which a sample is mounted. Other types of substrates will be readily apparent to those skilled in the art.
-8a-Referring to Figure 5, an alternative containment or confining means 200 comprises a plastic container sized to fit into receptacle 160 as illustrated generally at 200 in Figure 5. Container 200 comprises a plurality of separate compartments 202 each capable of containing a different solution. At least one of the plurality of separated compartments 202 would contain a solution of a single member of a ligand pair 209, while other compartments may contain solution of an enhancer 211 (i.e. an enzyme solution which enhances results by removing interfering substances) or a solution of one of the several components 213, 215 of the detection system used to detect the ligand previously released and now bound to its complementary partner in the biological material on the substrate. The open ends 204 of each compartment 202 may be seated with gelatin or wax sheets 208, 210. 212 and 214 which melt at the same or different temperatures depending on the application for which the ligand pair members are being used.
Referring now to Figures 6 and 7, an alternative cell body 302 has a cell head 304 integrally formed therewith as a single unitary piece.
Cell body 302 and head 304 are fabricated of a low thermally conductive material such as TEFLON~ or nylon. Cell body 302 includes a well 312 defined by wall 306. Cell head portion 304 includes an inclined surface 314 which acts as a receptacle into which a releasable containment means is inserted in use. Head portion 304 is heated by a heater element 316 embedded below inclined surface 314. Electrical conductors 308 provide power to heater 316. Cell body 302 is heated by a heater element 318 embedded in the body below wall 306. Conductors 310 provide power to heater 318. Cell body 302 and cell head 304 may be selectively heated in this way because cell block 302 is made of a low thermally conductive material. Tubes 330 and 332 are attached to the bottom of cell body 302 for supplying and draining reagents to and from the cell.
The fully automated system disclosed herein is advantageous in that it allows the concurrent demonstration of many different antigens when processing the biological samples with antibodylantigen systems.
Figure 1 illustrates an embodiment of the apparatus comprising 50 cells 14 -8b-but machines may be constructed with more or less cells depending on the anticipated load for the particular application. Apparatus 10 may house adequate stocks of the appropriate solvents, normal sera, secondary and tertiary immuno-labelling reagents and colour developing solutions. In one embodiment the apparatus may comprise a refrigeration unit for the pre-diluted primary and accessory antibodies in order to allow storing of reagents.
The set-up procedure comprises the three steps of: 1 ) placement of the substrates having the biological samples mounted thereon into cells 14; 2) inserting into chamber 160 a releasable containment means 162 containing at least one member of a ligand pair to be contacted with the biological sample; and 3) initiating the start sequence. The apparatus may-be adapted to perform the steps of: blocking endogenous enzyme activity (for peroxidase labelling WO 94/18539 ~ ~ 5 ~ 6 7 7 PCT/CA94100061 _g_ systems); proteolysis: blocking non-specific protein binding; multiple antibody incubations with intervening washes; colour development: and possibly counterstaining. The substrates are then manually removed from the machine for coverslipping and microscopical examination. Biological samples in the form of paraffin sections may be manually dewaxed prior to insertion into chamber 114. or alternatively the apparatus may be adapted to perform the steps of dewaxing and hydration. Specifically, with appropriate tubing, electrical insulation and locating the apparatus in a properly ventilated area, the steps of automated dewaxing and hydration of paraffin sections could be performed using known dewaxing and hydration agents such as xylene and alcohol solutions.
In operation, substrate 116, which supports a biological sample on one surface thereof, is inserted into chamber 114 with the sample facing well 38. A releasable containment means 162 (containing a ligand the other member of the pair) is placed in chamber 160. When used with the apparatus having heated components, containment means 162 is preferably a gelatin or wax solid matrix to be described in more detail below. Alternatively, containment means 162 may comprise a hollow capsule made of wax or gelatin. The gelatin and wax matrices are temperature sensitive so that at a certain predetermined temperature the capsule thermally degrades to release its contents. Cell body 34 is maintained at the optimum temperature for rapid and specific ligand pairing procedures. Once the support matrix/capsule 162 has been placed in cell head 50, the temperature of the head may be raised at some point during the procedure, so that the solid support matrix or capsule breaks down thereby releasing the reagent contained therein.
The releasable containment means may be made of a material which can be broken down or decomposed by any one of several physical or chemical processes such as by puncture, electrical, pressure, vacuum or exposure to EM radiation or solvents.
For example, when the releasable containment means is sucrose or starch (amylose or amylopectin) containing antibodies, decomposition may be achieved by exposure to aqueous or aqueous buffered solutions so that ~1~3~~~
head portion 50 need not be heated. When selecting a releasable containment system for a given ligand, it is important that the ligand and encapsulation material do not irreversibly bind Alternatively, chemical processes such as degradation or pH
change may be utilized as a release means to break down the matrix, this being accomplished by filling fluid well 38 and chamber 160 with a suitable reagent. When the releasible containment means is a membrane or solid matrix made of glyceryl mono-oleate (MYVEROL 18-99~) then decomposition may be effected by exposure to solutions of pH > 6.8. Release of DNA probes linked to a solid matrix through disulphide bonds may be achieved by dithiothreitol cleavage. Release of DNA probes bound to a solid matrix may also be effected by enzyme release through nuclease-specific auxiliary sequences.
One criterion for selecting the chemical release means is that the other components of the biological system are not adversely affected or interfered with by the chemical. The result of breaking down the matrix is to release the preservative medium containing the solution of antibodies which then flow through the fluid flow path through the cell into contact with the biological sample mounted on the substrate.
When the apparatus is used for immunocytochemical staining applications, the reagent encapsulated within the capsule comprises stabilized antibodies and is more fully discussed herebelow. However, apparatus 10 may be used for other applications involving the pairing of initially separate ligand pairs. Non-limiting examples of such ligand pairs includes lectinslsugars, hormone/receptor systems, enzymelsubstrates, DNA/DNA and DNA/RNA
couples to mention a few. The member of the ligand pair to be detected in a sample is mounted on substrate 116 within chamber 114 with the sample facing well 38 and the complementary member of the ligand pair is contained within a support matrix/capsule 162 mounted in chamber 160.
Antibody Stabilization And Support The highly specific nature of antibodies (or immunoglobulins) for recognizing different antigens forms the basis for immunocytochemistry (immunohistochemistry). In this technique the antigen of interest to be identified in biological samples is purified and an animal is immunized with the antigen thereby eliciting the synthesis of the specific antibodies. These antibodies may then be isolated and applied in-vitro to the sample. The antibodies bind to a site on the recognizable antigen in the sample and the resulting complexes may be detected by light microscopy using labels such as r~uorochromes, enzymes such as horseradish peroxidase and alkaline phosphate which in turn may be detected using histochemical reactions or colloidal metal particles which are detected using electron microscopy.
The antibodies are stabilized by being dissolved in a suitable stabilizing medium which in turn is releasably contained within a solid support matrix or capsule. The matrix may be a solid gelatin or wax block or a hollow capsule made or gelatin, wax or plastic which encapsulates the stabilizing medium containing the primary antibodies. The stabilizing medium may comprise a saline solution with a buffering system such as TRIZMAD based buffers, phosphate based buffers, citrate based buffers and the like. The stabilizing medium may also comprise detergents such as TRITON X-100'' (octyl phenoxy polyethoxy ethanol), NP40~ (octyl phenol ethylene oxide condensate), TWEEN 20~ (polyoxyethylene sorbitan rnonolaurate) and TWEEN
80'~ (polyoxyethylene sorbitan mono-oleate as well as biological compounds such as proteins, glycolipids, glycoproteins and antimicrobial agents such as thimerosal, sodium azide, sodium metabisulphite and the like. Gelatin is the preferred confining medium for the above referenced solutions while wax is . preferred for simple aqueous antibody solutions. Several examples of ' encapsulation systems are now described.
Example I
In this application, a solution of antibodies in suitable stabilizing medium is incorporated into a gelatin matrix with appropriate physical properties and sensitive to melting ioy heat at temperatures in for example the 35-45°C
range. This matrix has been tested for compatibility with the antibodies. and is composed of a 6% gelatin (300 bloom) in antibody preserving solution. The iaME~GED SHEET
WO 94/18539 ~' PCT/CA94/00061 antibody in gelatin matrix is formed into a convenient form, and solidified by reducing the temperature. The gelatin matrix may then be handled, shipped, stored, etc. To release the antibodies, the gelatin matrix is destroyed by heating to about 40°C. The matrix melts to form a gelatin/buffer solution which may flow into empty well 38 or mix with a reagent solvent or buffer previously admitted into the well through inlet tube 41 from the ,reagent supply.
Alternatively, the reagent buffer in well 38 may be displaced into chamber 160 by the gelatinlbuffer solution or it may be pumped out.
Examale II
In this application. the antibodies and subsequent reagents are incorporated into multiple gelatin or wax matrices which melt at temperatures in the 35-50 °C range. They are formed into a convenient physical shape, and the reagents are released as in Example I by heating and melting the matrix.
In this case, the different matrices are melted at different temperatures, reagent 1 is in a matrix melted at about 40°C, reagent 2 is in a matrix melted at about 45°C. and reagent 3 is in a matrix melted at about 50°C .
Example III
This example is similar to Examples I & II in that the different reagents are released by melting matrices which are sensitive to different temperature ranges. However, the reagents are in a liquid or semi-solid solution which is held in a capsule by the matrix barrier. Melting the matrix destroys the barrier, and the reagent is released into the buffer solution and reacts with the sample.
Those skilled in the art will appreciate that the method of supporting one member of a ligand pair in a support matrix forming part of the present invention is not limited to use with the automated apparatus also forming part of the present invention. For example, the support matrix containing one member of the ligand pair may be placed on a substrate having a sample mounted thereon. The release means, whether heat. solvent etc. is then applied to the support matrix to release the ligand member therefrom to
DETAILED DESCRIPTION OF THE INVENTION
Referring first to Figure 1, an automated apparatus 10 for performing the task of processing of biological materials includes a housing or sample compartment 12 comprising a plurality of sample cells 14 arranged in a rectangular array. A storage compartment 16 is located on one side of compartment 12 for housing fluid pumps, valves and reagents and a compartment 18 is located on the other side of compartment 12 for housing electronic control circuitry. An instrument panel comprising a microcomputer keypad 22 and a power switch 24 are shown as part of the control circuitry.
Details of sample cells 14 shown in Figure 1 are more clearly illustrated in Figures 2 and 3. Referring specifically to Figure 2, cells 14 are arranged in rows 30 with each row comprising a plurality of cell blocks 32 attached together. Cell block 32 includes a cell body 34 having on one side thereof a face 36 into which a rectangular shaped recess or well 38 is formed defined by wall 33. With reference to Figure 3, holes 37 and 39 are located along the bottom edge of well 38 and are in flow communication with tubes 41 and 43 respectively which are attached to the bottom of cell body 34 for supplying and draining reagents such as wash buffers to and from the cell.
In another embodiment of the cell, only one hole may be provided (not shown) for both supplying and draining reagents from the chamber. In this arrangement the hole is connected to a tube having a T junction and valve for providing a reagent inlet and outlet.
The other side of cell body 34 includes a wall 40 having a flange 42 projecting outwardly along three edges thereof. Flange 42 and cell body 34 are dimensioned so that the outer edge 44 of the flange abuts the edges of face 36 of the adjacent cell body 34 when assembled. Cell body 34 includes a liquid overflow comprising a channel 46 extending through the horizontal section of flange 42 and a tube 48 attached to the bottom edge of the flange to drain away liquid.
Referring to Figure 3, cell block 32 is provided with a head portion 50 shown attached to cell body 34 by screws 52. Alternative fastening means such as glues or epoxy may also be used. Cell body 34 and cell head 50 may be fabricated of a metal such as coated aluminum or stainless steel.
Interposed between cell body 34 and head portion 50 is a thermal insulator 54 for thermally insulating the head from the cell body. Insulator may be fabricated of a plastic such as nylon or TEFLON~. Channels 60 extend through cell body 34 and a channel 62 extends through cell head 50. Channels 60 and 62 are provided for passing fluid through the cell components for heating or cooling. Tubes 68 and 70 are secured to body 34 and head 50 respectively to provide fluid inlets and outlets. Cell body 34 and head 50 may be heated or cooled to the same temperature using a common source of heating fluid or alternatively they may be selectively heated or cooled using separate sources of fluid because of insulator 54 disposed therebetween.
In this embodiment, the apparatus 10 may include means for sensing the temperature of the cell portions.
One side of cell head 50 is provided with a surface 80 inclined at about 45 degrees to the horizontal when the cell is assembled. A leaf spring is secured to the other side of cell head 50 coplanar with wall 40 of cell body 34. Spring 82 is bowed outwardly from, and extends downwardly adjacent to, side 40 of cell body 34. The side of head 50 to which spring 82 is attached is provided with flanges 84 projecting outwardly from the side edges, flanges 84 being collinear with the vertical portions of flanges 42 on cell body 34 when the cell head is attached to the body to also sealingly engage face 36. Referring specifically to Figure 2, spring 82 acts to bias substrate 116 against face 36 but other alternative biasing means may be used including a piston arranged to bear against the back surface of the substrate slide.
Referring specifically to Figure 3, a front plate 86 is bolted to the adjacent cell block 32 at the front of each row 30. Plate 86 is provided with a planar front face 90 and back face 92 to which spring 82 is attached. The back face 92 includes a flange 42' projecting outwardly along three edges thereof and having an outer edge 44'.
A row of cells is assembled by aligning front plate 86 and a plurality of cell blocks 32 in a row and bolting them together with elongate bolts 110 extending through holes 112 in the plate and similar holes in the cell bodies 34. Alternative means of attaching the cell blocks together may be employed in addition to bolts.
Referring specifically to Figure 2, each cell 14 is formed when adjacent cell bodies 34 are attached together thereby defining a fluid chamber 114 formed between adjacent cell blocks 32. Chamber 114, which includes well 38, is defined by opposed walls 33 and 40 and is dimensioned to receive substrate 116 with the surface to which the biological material is mounted facing into well 38. Spring 82 acts to bias substrate 116 against cell body 34 with the edges of the substrate overlapping the sides and bottom edge of face 36 on either side of well 38 by about 2 mm to form a seal between the peripheral edge of substrate 116 and face 36.
The internal dimensions of fluid chamber 114 are chosen to ensure that a large enough gap exists between the opposed faces of substrate 116 and the adjacent chamber walls to prevent capillary action. For example, well 38 is of sufficient depth to prevent capillary action from retaining the fluids therein. The minimum allowable dimensions will depend on the material of construction of cell body 34 and on the material wetting properties. In one embodiment of the invention, each cell comprises fluid level sensor means (not shown) for detecting the level of a fluid in chamber 114.
A chamber or receptacle 160 is formed when cell 14 is assembled. Chamber 160 is in flow communication with well 38 when the substrate 116 is in chamber 114. Chamber 160 is dimensioned to receive a support matrix 162 containing a ligand, to be more fully discussed below. Cell head 50 may be constructed with chamber 160 having numerous shapes to act as a receptacle for support matrix 162 as long as there is an unobstructed flow path connecting chamber 160 with well 38.
Referring to Figure 4, a schematic drawing showing one _$.
embodiment of a reagent circulation system is shown generally at 130 and comprises a plurality of reagent storage containers 132 stored in reagent storage compartment 16 (Figure 1 ). Tubes 134 convey the reagents to the input of a reagent selection valve 136 located within the staining module 12, the output of which is fed to a reagent distribution value 138. Connectors 135 may be standard snap-fit connectors for conveniently connecting and disconnecting reagent containers 132. A plurality of tubes 140 connect valve 138 with chamber inlet control valves 142, one connected to each tube 41 for supplying reagents to each well 38, seen in Figure 3. Drain tubes 43 are connected to lines 150 which feeds into an outlet valve 152, the output of which is fed to a reagent waste container 154. Other fluid delivery systems will be readily apparent to those skilled in the art. For example, reagent selection valve 136 and reagent distribution valve 138 may be combined into one valve.
Alternatively, the function of reagent distribution valve 138 and chamber control valve 142 may be combined into one valve associated with each chamber.
Referring to Figure 2, cell body 34 and head portion 50 may be differentially heated or cooled by water circulated through the body and head by separate pumps and heaters. The pumps and heaters are controlled using standard controllers under microprocessor control. The controllers, pumps and microprocessor may be located in compartments 16 or 18 (Figure 1 ) or alternatively may be located external to apparatus 10.
Those skilled in the art will appreciate that numerous other embodiments of apparatus 10 may be made. For example, instead of differentially heating with water, small resistance electrical heaters may be embedded into cell body 34 and cell head 50, the heaters being connected to a dual channel electrical power supply. Standard thermocouples may be attached to the two cell components forming part of the control system.
Substrate 116 may be a standard microscope slide. However, other substrates may be used as well. For example, chamber 114 may be designed to receive substrates comprising an electron microscope grid on which a sample is mounted. Other types of substrates will be readily apparent to those skilled in the art.
-8a-Referring to Figure 5, an alternative containment or confining means 200 comprises a plastic container sized to fit into receptacle 160 as illustrated generally at 200 in Figure 5. Container 200 comprises a plurality of separate compartments 202 each capable of containing a different solution. At least one of the plurality of separated compartments 202 would contain a solution of a single member of a ligand pair 209, while other compartments may contain solution of an enhancer 211 (i.e. an enzyme solution which enhances results by removing interfering substances) or a solution of one of the several components 213, 215 of the detection system used to detect the ligand previously released and now bound to its complementary partner in the biological material on the substrate. The open ends 204 of each compartment 202 may be seated with gelatin or wax sheets 208, 210. 212 and 214 which melt at the same or different temperatures depending on the application for which the ligand pair members are being used.
Referring now to Figures 6 and 7, an alternative cell body 302 has a cell head 304 integrally formed therewith as a single unitary piece.
Cell body 302 and head 304 are fabricated of a low thermally conductive material such as TEFLON~ or nylon. Cell body 302 includes a well 312 defined by wall 306. Cell head portion 304 includes an inclined surface 314 which acts as a receptacle into which a releasable containment means is inserted in use. Head portion 304 is heated by a heater element 316 embedded below inclined surface 314. Electrical conductors 308 provide power to heater 316. Cell body 302 is heated by a heater element 318 embedded in the body below wall 306. Conductors 310 provide power to heater 318. Cell body 302 and cell head 304 may be selectively heated in this way because cell block 302 is made of a low thermally conductive material. Tubes 330 and 332 are attached to the bottom of cell body 302 for supplying and draining reagents to and from the cell.
The fully automated system disclosed herein is advantageous in that it allows the concurrent demonstration of many different antigens when processing the biological samples with antibodylantigen systems.
Figure 1 illustrates an embodiment of the apparatus comprising 50 cells 14 -8b-but machines may be constructed with more or less cells depending on the anticipated load for the particular application. Apparatus 10 may house adequate stocks of the appropriate solvents, normal sera, secondary and tertiary immuno-labelling reagents and colour developing solutions. In one embodiment the apparatus may comprise a refrigeration unit for the pre-diluted primary and accessory antibodies in order to allow storing of reagents.
The set-up procedure comprises the three steps of: 1 ) placement of the substrates having the biological samples mounted thereon into cells 14; 2) inserting into chamber 160 a releasable containment means 162 containing at least one member of a ligand pair to be contacted with the biological sample; and 3) initiating the start sequence. The apparatus may-be adapted to perform the steps of: blocking endogenous enzyme activity (for peroxidase labelling WO 94/18539 ~ ~ 5 ~ 6 7 7 PCT/CA94100061 _g_ systems); proteolysis: blocking non-specific protein binding; multiple antibody incubations with intervening washes; colour development: and possibly counterstaining. The substrates are then manually removed from the machine for coverslipping and microscopical examination. Biological samples in the form of paraffin sections may be manually dewaxed prior to insertion into chamber 114. or alternatively the apparatus may be adapted to perform the steps of dewaxing and hydration. Specifically, with appropriate tubing, electrical insulation and locating the apparatus in a properly ventilated area, the steps of automated dewaxing and hydration of paraffin sections could be performed using known dewaxing and hydration agents such as xylene and alcohol solutions.
In operation, substrate 116, which supports a biological sample on one surface thereof, is inserted into chamber 114 with the sample facing well 38. A releasable containment means 162 (containing a ligand the other member of the pair) is placed in chamber 160. When used with the apparatus having heated components, containment means 162 is preferably a gelatin or wax solid matrix to be described in more detail below. Alternatively, containment means 162 may comprise a hollow capsule made of wax or gelatin. The gelatin and wax matrices are temperature sensitive so that at a certain predetermined temperature the capsule thermally degrades to release its contents. Cell body 34 is maintained at the optimum temperature for rapid and specific ligand pairing procedures. Once the support matrix/capsule 162 has been placed in cell head 50, the temperature of the head may be raised at some point during the procedure, so that the solid support matrix or capsule breaks down thereby releasing the reagent contained therein.
The releasable containment means may be made of a material which can be broken down or decomposed by any one of several physical or chemical processes such as by puncture, electrical, pressure, vacuum or exposure to EM radiation or solvents.
For example, when the releasable containment means is sucrose or starch (amylose or amylopectin) containing antibodies, decomposition may be achieved by exposure to aqueous or aqueous buffered solutions so that ~1~3~~~
head portion 50 need not be heated. When selecting a releasable containment system for a given ligand, it is important that the ligand and encapsulation material do not irreversibly bind Alternatively, chemical processes such as degradation or pH
change may be utilized as a release means to break down the matrix, this being accomplished by filling fluid well 38 and chamber 160 with a suitable reagent. When the releasible containment means is a membrane or solid matrix made of glyceryl mono-oleate (MYVEROL 18-99~) then decomposition may be effected by exposure to solutions of pH > 6.8. Release of DNA probes linked to a solid matrix through disulphide bonds may be achieved by dithiothreitol cleavage. Release of DNA probes bound to a solid matrix may also be effected by enzyme release through nuclease-specific auxiliary sequences.
One criterion for selecting the chemical release means is that the other components of the biological system are not adversely affected or interfered with by the chemical. The result of breaking down the matrix is to release the preservative medium containing the solution of antibodies which then flow through the fluid flow path through the cell into contact with the biological sample mounted on the substrate.
When the apparatus is used for immunocytochemical staining applications, the reagent encapsulated within the capsule comprises stabilized antibodies and is more fully discussed herebelow. However, apparatus 10 may be used for other applications involving the pairing of initially separate ligand pairs. Non-limiting examples of such ligand pairs includes lectinslsugars, hormone/receptor systems, enzymelsubstrates, DNA/DNA and DNA/RNA
couples to mention a few. The member of the ligand pair to be detected in a sample is mounted on substrate 116 within chamber 114 with the sample facing well 38 and the complementary member of the ligand pair is contained within a support matrix/capsule 162 mounted in chamber 160.
Antibody Stabilization And Support The highly specific nature of antibodies (or immunoglobulins) for recognizing different antigens forms the basis for immunocytochemistry (immunohistochemistry). In this technique the antigen of interest to be identified in biological samples is purified and an animal is immunized with the antigen thereby eliciting the synthesis of the specific antibodies. These antibodies may then be isolated and applied in-vitro to the sample. The antibodies bind to a site on the recognizable antigen in the sample and the resulting complexes may be detected by light microscopy using labels such as r~uorochromes, enzymes such as horseradish peroxidase and alkaline phosphate which in turn may be detected using histochemical reactions or colloidal metal particles which are detected using electron microscopy.
The antibodies are stabilized by being dissolved in a suitable stabilizing medium which in turn is releasably contained within a solid support matrix or capsule. The matrix may be a solid gelatin or wax block or a hollow capsule made or gelatin, wax or plastic which encapsulates the stabilizing medium containing the primary antibodies. The stabilizing medium may comprise a saline solution with a buffering system such as TRIZMAD based buffers, phosphate based buffers, citrate based buffers and the like. The stabilizing medium may also comprise detergents such as TRITON X-100'' (octyl phenoxy polyethoxy ethanol), NP40~ (octyl phenol ethylene oxide condensate), TWEEN 20~ (polyoxyethylene sorbitan rnonolaurate) and TWEEN
80'~ (polyoxyethylene sorbitan mono-oleate as well as biological compounds such as proteins, glycolipids, glycoproteins and antimicrobial agents such as thimerosal, sodium azide, sodium metabisulphite and the like. Gelatin is the preferred confining medium for the above referenced solutions while wax is . preferred for simple aqueous antibody solutions. Several examples of ' encapsulation systems are now described.
Example I
In this application, a solution of antibodies in suitable stabilizing medium is incorporated into a gelatin matrix with appropriate physical properties and sensitive to melting ioy heat at temperatures in for example the 35-45°C
range. This matrix has been tested for compatibility with the antibodies. and is composed of a 6% gelatin (300 bloom) in antibody preserving solution. The iaME~GED SHEET
WO 94/18539 ~' PCT/CA94/00061 antibody in gelatin matrix is formed into a convenient form, and solidified by reducing the temperature. The gelatin matrix may then be handled, shipped, stored, etc. To release the antibodies, the gelatin matrix is destroyed by heating to about 40°C. The matrix melts to form a gelatin/buffer solution which may flow into empty well 38 or mix with a reagent solvent or buffer previously admitted into the well through inlet tube 41 from the ,reagent supply.
Alternatively, the reagent buffer in well 38 may be displaced into chamber 160 by the gelatinlbuffer solution or it may be pumped out.
Examale II
In this application. the antibodies and subsequent reagents are incorporated into multiple gelatin or wax matrices which melt at temperatures in the 35-50 °C range. They are formed into a convenient physical shape, and the reagents are released as in Example I by heating and melting the matrix.
In this case, the different matrices are melted at different temperatures, reagent 1 is in a matrix melted at about 40°C, reagent 2 is in a matrix melted at about 45°C. and reagent 3 is in a matrix melted at about 50°C .
Example III
This example is similar to Examples I & II in that the different reagents are released by melting matrices which are sensitive to different temperature ranges. However, the reagents are in a liquid or semi-solid solution which is held in a capsule by the matrix barrier. Melting the matrix destroys the barrier, and the reagent is released into the buffer solution and reacts with the sample.
Those skilled in the art will appreciate that the method of supporting one member of a ligand pair in a support matrix forming part of the present invention is not limited to use with the automated apparatus also forming part of the present invention. For example, the support matrix containing one member of the ligand pair may be placed on a substrate having a sample mounted thereon. The release means, whether heat. solvent etc. is then applied to the support matrix to release the ligand member therefrom to
Claims (21)
1. An apparatus for processing biological materials using ligand pairing, the biological material being mounted on a surface of a substrate, comprising:
a) a housing provided with at least one cell, said at least one cell comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening;
b) means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and c) a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
a) a housing provided with at least one cell, said at least one cell comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening;
b) means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and c) a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
2. The apparatus according to claim 1 wherein said first cell portion and said second cell portion are separated by a thermal insulator.
3. The apparatus according to claim 2 including a means for selectively heating or cooling at least one of said first and second cell portions, said means for heating or cooling being thermally contacted to each of said first and second cell portions.
4. The apparatus according to claim 3 wherein said means for heating at least one of said first and second cell portions comprises electrical heating elements thermally contacted to said first and second cell portions.
5. The apparatus according to claim 3 or 4 including means for sensing the temperature of said first and second cell portions.
6. The apparatus according to any one of claims 3 to 5 including water flow passageways extending through said first and second cell portions, wherein said means for selectively heating said first cell portion and said second cell portion comprises passing water at predetermined temperatures through said water flow passageways in said first and second cell portions.
7. The apparatus according to any one of claims 1 to 6 wherein said cell comprises fluid level sensor means for detecting the level of a fluid in said first chamber.
8. The apparatus according to claim 1 wherein said at least one cell is fabricated of a thermal insulating material.
9. The apparatus according to claim 8 including means for heating or cooling at least one of said first and second cell portions.
10. The apparatus according to claim 9 wherein said means for heating at least one of said first and second cell portions comprises electrical heating elements thermally contacted to said first and second cell portions.
11. The apparatus according to claim 9 or 10 including means for sensing the temperature of said first and second cell portions.
12. The apparatus according to claim 9 including water flow passageways extending through said first and second cell portions, wherein said means for selectively heating said first cell portion and said second cell portion comprises passing water at predetermined temperatures through said water flow passageways in said first and second cell portions.
13. The apparatus according to any one of claims 8 to 12 wherein said cell comprises fluid level sensor means for detecting the level of a fluid in said first chamber.
14. An apparatus for processing biological materials using ligand pairing, the biological material being mounted on a surface of a substrate, comprising:
a) a housing provided with an array of cells, each cell of said array comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening, the first and second cell portions being separated by a thermal insulator;
b) means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and c) a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
a) a housing provided with an array of cells, each cell of said array comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening, the first and second cell portions being separated by a thermal insulator;
b) means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and c) a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
15. The apparatus according to claim 14 including a means for selectively heating or cooling each of said first and second cell portions, said means for heating or cooling being thermally contacted to each of said first and second cell portions, and means for sensing the temperature of said first and second cell portions.
16. The apparatus according to claim 15 wherein said means for heating each of said first and second cell portions comprises electrical heating elements being thermally contacted to said first and second cell portions.
17. The apparatus according to any one of claims 14 to 16 wherein said cell comprises fluid level sensor means for detecting the level of a fluid in said first chamber.
18. An apparatus for processing biological materials using ligand pairing, the biological material being mounted on a surface of a substrate, comprising:
a) a housing provided with at least one cell fabricated of a thermally insulating material, said at least one cell comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening;
b) means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and c) a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
a) a housing provided with at least one cell fabricated of a thermally insulating material, said at least one cell comprising a first cell portion defining a first chamber having a first opening and having opposed first and second chamber walls, said first chamber wall having a raised peripheral edge portion and said substrate overlapping said raised peripheral edge portion when inserted into said first chamber so that said surface of the substrate is spaced from said first chamber wall a sufficient distance to prevent capillary action from retaining a liquid therebetween, a second cell portion defining a second chamber with a second opening to receive therein a ligand, the second chamber being in fluid flow communication with said first chamber through said first opening;
b) means for biasing said substrate against said raised peripheral edge portion in sealing engagement therewith; and c) a reagent supply means for supplying reagent solutions to said first chamber and a drainage passageway in flow communication with said first chamber for draining said reagent solutions from said first chamber.
19. The apparatus according to claim 18 including a means for selectively heating or cooling each of said first and second cell portions, said means for heating or cooling being thermally contacted to each of said first and second cell portions, and means for sensing the temperature of said first and second cell portions.
20. The apparatus according to claim 19 wherein said means for heating each of said first and second cell portions comprises electrical heating elements being thermally contacted to said first and second cell portions.
21. The apparatus according to any one of claims 18 to 20 wherein said cell comprises fluid level sensor means for detecting the level of a fluid in said first chamber.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA002451940A CA2451940C (en) | 1993-02-03 | 1994-02-03 | Method of storing a ligand in a releasable containment means and method of releasing a ligand therefrom |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1285693A | 1993-02-03 | 1993-02-03 | |
| US08/012,856 | 1993-02-03 | ||
| PCT/CA1994/000061 WO1994018539A2 (en) | 1993-02-03 | 1994-02-03 | Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002451940A Division CA2451940C (en) | 1993-02-03 | 1994-02-03 | Method of storing a ligand in a releasable containment means and method of releasing a ligand therefrom |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2153677A1 CA2153677A1 (en) | 1994-08-18 |
| CA2153677C true CA2153677C (en) | 2005-01-04 |
Family
ID=21757058
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002153677A Expired - Lifetime CA2153677C (en) | 1993-02-03 | 1994-02-03 | Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5695942A (en) |
| EP (2) | EP0682775B1 (en) |
| AT (2) | ATE165917T1 (en) |
| AU (1) | AU5997194A (en) |
| CA (1) | CA2153677C (en) |
| DE (2) | DE69430679T2 (en) |
| DK (2) | DK0826955T3 (en) |
| ES (2) | ES2119166T3 (en) |
| PT (1) | PT826955E (en) |
| WO (1) | WO1994018539A2 (en) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0843169B1 (en) * | 1995-02-25 | 2003-03-19 | Roche Diagnostics GmbH | Device for treating samples on microscope slides |
| US5959098A (en) | 1996-04-17 | 1999-09-28 | Affymetrix, Inc. | Substrate preparation process |
| SE9500777D0 (en) * | 1995-03-03 | 1995-03-03 | Pharmacia Ab | Provrörshållarinsats |
| US6177282B1 (en) * | 1997-08-12 | 2001-01-23 | Mcintyre John A. | Antigens embedded in thermoplastic |
| CA2301539C (en) * | 1997-09-11 | 2003-06-17 | Genovations, Inc. | Method of making high density arrays |
| NO306357B1 (en) * | 1997-10-16 | 1999-10-25 | Torstein Ljungmann | Color machine for preparation of tissue samples placed on slides |
| CA2720326C (en) * | 1997-12-23 | 2014-11-25 | Dako Denmark A/S | Cartridge device for processing a sample mounted on a surface of a support member |
| US6855559B1 (en) | 1998-09-03 | 2005-02-15 | Ventana Medical Systems, Inc. | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
| US6143512A (en) * | 1998-08-17 | 2000-11-07 | Markovic; Nenad | Cap-pap test |
| CN100389314C (en) * | 1998-09-03 | 2008-05-21 | 文塔纳医疗系统公司 | Removal of embedding media from biological samples and adjusting cell condition on automated staining instruments |
| US6855552B2 (en) | 1998-09-03 | 2005-02-15 | Ventana Medical Systems | Automated immunohistochemical and in situ hybridization assay formulations |
| US7410753B2 (en) * | 1998-09-03 | 2008-08-12 | Ventana Medical Systems, Inc. | Removal of embedding media from biological samples and cell conditioning on automated staining instruments |
| US6673620B1 (en) * | 1999-04-20 | 2004-01-06 | Cytologix Corporation | Fluid exchange in a chamber on a microscope slide |
| DE19932958C2 (en) * | 1999-07-14 | 2003-08-07 | Walter Schubert | Device for binding molecules, groups of molecules, parts of molecules and / or cells |
| US6930292B1 (en) | 1999-07-21 | 2005-08-16 | Dako A/S | Method of controlling the temperature of a specimen in or on a solid support member |
| FR2806166B1 (en) * | 2000-03-09 | 2002-11-15 | Genomic Sa | AUTOMATON FOR PROCESSING, SIGNAL ACQUISITION AND ANALYSIS OF BIOCHIPS |
| US6465207B1 (en) | 2000-11-03 | 2002-10-15 | Cytologix Corporation | Silver-based staining processes employing non-gelling gelatin |
| US6828154B1 (en) | 2000-11-03 | 2004-12-07 | Cytologix Corporation | Staining method with chromic acid precursors |
| US6713023B2 (en) * | 2001-06-29 | 2004-03-30 | Agilent Technologies, Inc. | Flow cell for chemical reactions |
| US6773677B2 (en) * | 2002-01-09 | 2004-08-10 | Caliper Life Sciences, Inc. | Slide cassette for fluidic injection |
| WO2004083824A1 (en) * | 2003-03-20 | 2004-09-30 | Dakocytomation Denmark A/S | System for establishing a sample cover on a substrate |
| US7767152B2 (en) | 2003-08-11 | 2010-08-03 | Sakura Finetek U.S.A., Inc. | Reagent container and slide reaction retaining tray, and method of operation |
| NO321928B1 (en) * | 2004-12-23 | 2006-07-24 | Oystein Ljungmann | Method and system for using treatment liquids in an apparatus for staining tissue samples on slides |
| EP1846745A2 (en) * | 2004-12-30 | 2007-10-24 | Ventana Medical Systems, Inc. | Low temperature deparaffinization |
| CA2535317C (en) | 2005-02-11 | 2010-04-13 | Sakura Finetek U.S.A., Inc. | Reagent container and slide reaction and retaining tray, and method of operation |
| US7666358B2 (en) * | 2006-10-20 | 2010-02-23 | Cytyc Corporation | Cell block cassette device |
| WO2009099872A2 (en) * | 2008-01-31 | 2009-08-13 | Kacey Med-Vet, Inc. | Automated stainer having stain level detection |
| US8975039B2 (en) * | 2008-06-09 | 2015-03-10 | SYFR, Inc. | Automatic sample staining method |
| DE102009013534A1 (en) * | 2009-03-19 | 2010-09-23 | Crinotec Gmbh | Method and device for determining an impurity content in a matrix |
| EP2686662B1 (en) * | 2011-02-28 | 2022-01-19 | Agilent Technologies, Inc. | Two phase immiscible system for the pretreatment of embedded biological samples |
| US8869666B2 (en) | 2011-03-24 | 2014-10-28 | Sakura Finetek U.S.A., Inc. | Microtome with surface orientation sensor to sense orientation of surface of sample |
| US9032854B2 (en) | 2011-12-21 | 2015-05-19 | Sakura Finetek U.S.A., Inc. | Reciprocating microtome drive system |
| CN104583754A (en) | 2012-06-22 | 2015-04-29 | 莱卡生物系统努斯洛赫有限责任公司 | Tissue sample container and methods |
| EP2864467B1 (en) | 2012-06-22 | 2019-04-03 | Leica Biosystems Nussloch GmbH | Biopsy tissue sample transport device |
| US9052256B2 (en) | 2013-03-15 | 2015-06-09 | Leica Biosystems Nussloch Gmbh | Method for processing and embedding tissue |
| CA2845832C (en) | 2013-03-15 | 2020-09-22 | Leica Biosystems Nussloch Gmbh | Tissue cassette with biasing element |
| US9097629B2 (en) | 2013-03-15 | 2015-08-04 | Leica Biosystems Nussloch Gmbh | Tissue cassette with retractable member |
| RU2699612C2 (en) | 2015-05-29 | 2019-09-06 | Иллюмина, Инк. | Sample cassette and analytical system for carrying out certain reactions |
| US11221281B2 (en) * | 2016-03-21 | 2022-01-11 | Xiamen Talent Biomedical Technology Company, Ltd. | Heat treatment device for slide specimen testing |
| JP6692487B2 (en) * | 2016-03-21 | 2020-05-13 | 厦門通霊生物医薬科技有限公司Ｘｉａｍｅｎ Ｔａｌｅｎｔ Ｂｉｏｍｅｄｉｃａｌ Ｔｅｃｈｎｏｌｏｇｙ Ｃｏｍｐａｎｙ，Ｌｔｄ． | Slide support device for sample slide processing |
| WO2017218882A1 (en) * | 2016-06-16 | 2017-12-21 | Nanocytomics, LLC | Automated staining system |
| WO2019209290A1 (en) | 2018-04-25 | 2019-10-31 | Hewlett-Packard Development Company, L.P. | Selective release of material in thermally degradable capsule |
| WO2023210383A1 (en) * | 2022-04-28 | 2023-11-02 | 富士フイルム株式会社 | Inspection device |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3495926A (en) * | 1966-11-02 | 1970-02-17 | John F Naz | Method and apparatus for staining microslides |
| US3898982A (en) * | 1972-11-13 | 1975-08-12 | Jintan Terumo Co | Capillary tube for blood examination |
| US4255411A (en) * | 1978-11-27 | 1981-03-10 | Damon Corporation | Process of determining an immunogenic substance by competition with an antibody in a microcapsule |
| US4384193A (en) * | 1981-06-09 | 1983-05-17 | Immulok, Inc. | Incubating device for specimen mounted on glass slides in immunoassays |
| FI852736A0 (en) * | 1985-07-10 | 1985-07-10 | Labsystems Oy | THERMOSTERBAR CAN SEE. |
| US4756884A (en) * | 1985-08-05 | 1988-07-12 | Biotrack, Inc. | Capillary flow device |
| CA1281283C (en) * | 1985-08-29 | 1991-03-12 | Elazar Rabbani | Method for detecting an analyte moiety by means of signal localization |
| US4731335A (en) * | 1985-09-13 | 1988-03-15 | Fisher Scientific Company | Method for treating thin samples on a surface employing capillary flow |
| US5068198A (en) * | 1986-03-26 | 1991-11-26 | Syntex (U.S.A.) Inc. | Liquid single reagent for assays involving confining gels |
| ES2059339T3 (en) * | 1986-10-23 | 1994-11-16 | Behringwerke Ag | POROUS SOLID PHASES BIOAFINES, A PROCEDURE FOR THE PREPARATION OF POROUS SOLID PHASES BIOAFINES AND THEIR USE. |
| USH349H (en) * | 1987-03-12 | 1987-10-06 | The United States Of America As Represented By The Secretary Of The Army | Inert solid compositions which become chemically reactive when molten |
| US4847208A (en) * | 1987-07-29 | 1989-07-11 | Bogen Steven A | Apparatus for immunohistochemical staining and method of rinsing a plurality of slides |
| GB8722902D0 (en) * | 1987-09-30 | 1987-11-04 | Shandon Southern Prod | Tissue &c processing |
| US4985082A (en) * | 1987-11-20 | 1991-01-15 | Lafayette Applied Chemistry, Inc. | Microporous granular starch matrix compositions |
| US4908319A (en) * | 1988-03-16 | 1990-03-13 | Smyczek Peter J | Laboratory apparatus |
| GB8813628D0 (en) * | 1988-06-09 | 1988-07-13 | Shandon Southern Prod | Immunostaining |
| CA2028804C (en) * | 1989-11-21 | 2000-06-20 | Howard J. Buttery | Biomosaic polymers and method for preparing same |
| US5273905A (en) * | 1991-02-22 | 1993-12-28 | Amoco Corporation | Processing of slide mounted material |
| DE4117830A1 (en) * | 1991-05-29 | 1992-12-03 | Medite Ges Fuer Medizintechnik | Histological preparation colour treatment station trough - has heating elements mounted on or integrated into trough and temp. sensors connected to controller |
| US5413924A (en) * | 1992-02-13 | 1995-05-09 | Kosak; Kenneth M. | Preparation of wax beads containing a reagent for release by heating |
-
1994
- 1994-02-03 DE DE69430679T patent/DE69430679T2/en not_active Expired - Lifetime
- 1994-02-03 DK DK97118652T patent/DK0826955T3/en active
- 1994-02-03 US US08/387,813 patent/US5695942A/en not_active Expired - Lifetime
- 1994-02-03 WO PCT/CA1994/000061 patent/WO1994018539A2/en active IP Right Grant
- 1994-02-03 CA CA002153677A patent/CA2153677C/en not_active Expired - Lifetime
- 1994-02-03 ES ES94906107T patent/ES2119166T3/en not_active Expired - Lifetime
- 1994-02-03 ES ES97118652T patent/ES2176588T3/en not_active Expired - Lifetime
- 1994-02-03 AU AU59971/94A patent/AU5997194A/en not_active Abandoned
- 1994-02-03 DE DE69410084T patent/DE69410084T2/en not_active Expired - Lifetime
- 1994-02-03 AT AT94906107T patent/ATE165917T1/en not_active IP Right Cessation
- 1994-02-03 DK DK94906107T patent/DK0682775T3/en active
- 1994-02-03 PT PT97118652T patent/PT826955E/en unknown
- 1994-02-03 AT AT97118652T patent/ATE217973T1/en not_active IP Right Cessation
- 1994-02-03 EP EP94906107A patent/EP0682775B1/en not_active Expired - Lifetime
- 1994-02-03 EP EP97118652A patent/EP0826955B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DK0682775T3 (en) | 1999-02-15 |
| EP0682775A1 (en) | 1995-11-22 |
| DE69410084T2 (en) | 1999-01-21 |
| EP0682775B1 (en) | 1998-05-06 |
| PT826955E (en) | 2002-09-30 |
| EP0826955B1 (en) | 2002-05-22 |
| ES2119166T3 (en) | 1998-10-01 |
| AU5997194A (en) | 1994-08-29 |
| CA2153677A1 (en) | 1994-08-18 |
| ATE217973T1 (en) | 2002-06-15 |
| ATE165917T1 (en) | 1998-05-15 |
| DE69430679T2 (en) | 2002-12-19 |
| DK0826955T3 (en) | 2002-08-19 |
| WO1994018539A2 (en) | 1994-08-18 |
| DE69430679D1 (en) | 2002-06-27 |
| WO1994018539A3 (en) | 1994-09-29 |
| DE69410084D1 (en) | 1998-06-10 |
| EP0826955A2 (en) | 1998-03-04 |
| EP0826955A3 (en) | 1999-03-03 |
| ES2176588T3 (en) | 2002-12-01 |
| US5695942A (en) | 1997-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2153677C (en) | Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials | |
| US5965454A (en) | Automated histo-cytochemistry apparatus and encapsulation system for processing biological materials | |
| US7598036B2 (en) | Apparatus and methods for efficient processing of biological samples on slides | |
| ES2919425T3 (en) | In situ antigen retrieval procedures from a biological sample and imaging thereof | |
| ES2354598T3 (en) | AUTOMATED MOLECULAR PATHOLOGY DEVICE THAT HAS INDEPENDENT CARRIER HEATERS. | |
| US6395536B2 (en) | Sample processing device with a chamber forming member | |
| Brigati et al. | Immunocytochemistry is automated: development of a robotic workstation based upon the capillary action principle | |
| US6703247B1 (en) | Apparatus and methods for efficient processing of biological samples on slides | |
| US20040141880A1 (en) | System and cartridge for processing a biological sample | |
| JPH05240748A (en) | Method for treating thin piece sample on surface by capillary flow | |
| US7410753B2 (en) | Removal of embedding media from biological samples and cell conditioning on automated staining instruments | |
| EP1887363A1 (en) | Micro overall analysis system, inspection chip, and inspection method | |
| Sanderson et al. | 19—Immunohistochemical and immunofluorescent techniques | |
| US20030211630A1 (en) | Automated molecular pathology apparatus having independent slide heaters | |
| US6338969B1 (en) | Assay test system for regulating temperature | |
| JP2004525366A (en) | Automated immunohistochemistry and in situ hybridization assay formulations | |
| MXPA01003354A (en) | Nucleic acid amplification reaction station for disposable test devices. | |
| US3811842A (en) | Temperature-controlled fluid manifold for a fluid manifold for a fluid system of an automated sample analyzer | |
| US20060216744A1 (en) | Apparatus and methods for efficient processing of biological samples on slides | |
| CA2451940C (en) | Method of storing a ligand in a releasable containment means and method of releasing a ligand therefrom | |
| US20210172967A1 (en) | Microscope slide processing systems, consumable stainer modules, and methods of using the same | |
| CA1336653C (en) | Method and apparatus for treating thin sample on a surface employing capillary flow | |
| US20190234842A1 (en) | System, method and kit for sample preparation | |
| AU2004205218A1 (en) | Apparatus and methods for efficient processing of biological samples on slides | |
| US8026106B1 (en) | Removal of mercuric chloride crystals from fixed tissues |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20140203 |